Lv1
30 积分 2023-05-21 加入
Clinical and Biochemical Data for the Diagnosis of Endogenous Hypercortisolism: The “Cushingomic” Approach
3天前
已完结
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
1个月前
已完结
Challenges and opportunities in NASH drug development
2个月前
已完结
A disease‐specific quality of life instrument for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: CLDQ‐NAFLD
3个月前
已完结
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
3个月前
已完结
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
3个月前
已完结
Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease
3个月前
已完结
The Harvard Medical School Pathways curriculum: A comprehensive curricular evaluation
7个月前
已完结
Serum IGF-1 In the Diagnosis of Acromegaly and the Profile of Patients with Elevated IGF-1 but Normal Glucose-Suppressed Growth Hormone
9个月前
已完结
Effective Long-Term Treatment of Cushing’s Disease with Pasireotide: A Case Report
9个月前
已完结
皖公网安备34019202002308
